Sleep aid and bladder drug tested to ease stent discomfort
NCT ID NCT07617922
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares melatonin, solifenacin, and their combination to reduce bothersome urinary symptoms and pain caused by a temporary ureteral stent placed after kidney stone surgery. About 189 adults will take one of the two drugs or both for 14 days. The goal is to see which approach improves quality of life and sleep the most.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Urology- Beni-Suef University Hospitals
RECRUITINGBanī Suwayf, BeniSuef, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a fluid injection make prostate surgery safer and less bloody?
- Can a softer stent spare kids from bladder spasms?
- Can a two-drug combo better tame prostate trouble?
- Can adjusting drug schedules improve both urinary and sexual outcomes in men with enlarged prostate?
- Laser surgery before radiation may ease urinary troubles in prostate cancer patients
- Soothing sounds and soft lights may ease patient nerves during bladder exams